top of page
Search


Regulatory Horizon 2026: Navigating Innovation, Risk, and Excellence in Pharmaceuticals
Key global regulators such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO) are constantly updating their rules. This is a direct response to the increasing complexity of new therapies and global supply chains. Their goal is to ensure innovation never comes at the cost of patient safety or product quality.
Akshay Gautam
22 hours ago13 min read


Walter Healthcare’s Vitamin D3 Nanoshots: Advancing nanoemulsion science
The easy insight into the VitaminD3 nanoshot, its usage, and the science associated with it.
Akshay Gautam
Dec 20, 20259 min read


Amoxycillin-Clavulanic Acid Formulation: A Powerful Dual-Action Antibiotic Formula
It provides essential coverage for a wide range of conditions, from respiratory and skin infections to various mixed bacterial ailments across all age groups, particularly when single-agent antibiotics fail.
The power of this formulation lies in its strategic, dual-action mechanism. Amoxycillin offers potent, broad-spectrum bactericidal activity. Simultaneously, Clavulanic Acid acts as a guardian, breaking down the resistance mechanisms that bacteria use to neutralize the a
Akshay Gautam
Nov 26, 202511 min read


How the India–UK FTA Opens New Doors for Indian Pharma & CDMOs
The India-UK Free Trade Agreement unlocks zero-duty access and faster approvals for Indian pharma exports, paving the way for deeper...
Akshay Gautam
Aug 2, 202511 min read
Home >> Pharma News & Blog
bottom of page